LPS INDUCED ENDOTHELIAL CELL ACTIVATION AND APOPTOSIS
LPS 诱导内皮细胞活化和凋亡
基本信息
- 批准号:6519351
- 负责人:
- 金额:$ 23.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-04-01 至 2004-05-31
- 项目状态:已结题
- 来源:
- 关键词:apoptosis bacterial proteins binding proteins blood toxicology cellular immunity cysteine endopeptidases cytokine receptors human tissue immunocytochemistry inflammation interleukin 1 ischemia laboratory mouse leukocyte activation /transformation leukocyte adhesion molecules lipopolysaccharides macrophage monocyte nuclear factor kappa beta protein structure function reperfusion tissue /cell culture tumor necrosis factor alpha vascular endothelium western blottings
项目摘要
Septic shock is a potentially lethal consequence of gram negative
and positive bacterial infection and is a significant complication in victims
of traumatic injury. There are multiple bacterial products implicated as
pathogenic molecules including bacterial lipoproteins, lipopolysaccharide,
(LPS), lipoteichoic acid, peptidoglycans, cell wall products, etc. Sepsis in
experimental animals was shown to activate the intrinsic cell "suicide" program
leading to apoptosis in multiple cell types. Insights into the molecular basis
of cellular activation/apoptosis in response to sepsis are under intense
investigation in the hope of finding new approaches to therapy. Signaling by
bacterial products occurs through the recently described Toll-like receptors
(TLR) on the surface of cells. Intracellular pathways leading to NFkappaB
activation proceed along similar pathways for TLR-2 and TLR-4 (the two
receptors shown to respond to bacterial products). However, apoptosis pathways
have received less attention. The investigators will examine sepsis-induced
apoptosis and a novel activation pathway in vitro as well as the effect of gene
alterations that lead to decreased apoptosis in monocytes, lymphocytes and
endothelial cells in vivo. They have recently shown that the apoptotic pathway
following stimulation with LPS proceeds through FADD dependent signaling and
that blockade of NFkappaB does not sensitize endothelial cells to death. These
observation lead to questions regarding the death pathway and intrinsic
cyto-protective pathways. Since considerable apoptosis occurs in LPS resistant
(TLR-4 deficient) mice during sepsis, we also speculate that TLR-2 provides
both activation signals and death signals in TLR-4 deficient mice. Also, they
have observed two pathways leading to endothelial cell activation. First, mice
lacking functional Fas (lpr) or FasL (gld) have reduced responses to LPS, and
they postulate that the Fas-FasL system is pro-imflammatory. Second, a specific
caspase-8 inhibitor reduces LPS-induced VCAM-1 expression. They postulate that
this protease also signals for endothelial cell activation. The specific aims
of this project are: 1) To determine the role of MyD88, Il-1 receptor-
associated kinase and TNF receptor- associated factor-6 in sepsis-induced
apoptosis of monocytes/macrophages and endothelial cells; 2) To determine the
contribution of Fas-FasL and other molecules in that apoptosis pathway in
LPS-induced inflammatory response of endothelial cells; and 3) To examine the
effects of apoptotic gene alterations in monocytes, lymphocytes or endothelial
in survival following induction of sepsis in mice.
感染性休克是革兰氏阴性菌的潜在致命后果
和阳性细菌感染,是受害者的严重并发症
的外伤。有多种细菌产物涉及
致病分子包括细菌脂蛋白、脂多糖、
(LPS)、脂磷壁酸、肽聚糖、细胞壁产物等。脓毒症
实验动物被证明可以激活细胞内在的“自杀”程序
导致多种细胞类型凋亡。深入了解分子基础
脓毒症反应中的细胞活化/凋亡受到强烈影响
进行调查,希望找到新的治疗方法。发信号由
细菌产物通过最近描述的 Toll 样受体产生
(TLR) 位于细胞表面。导致 NFkappaB 的细胞内途径
TLR-2 和 TLR-4 的激活沿着相似的途径进行(这两个途径
显示对细菌产物有反应的受体)。然而,细胞凋亡途径
受到的关注较少。研究人员将检查败血症引起的
细胞凋亡和体外新的激活途径以及基因的作用
导致单核细胞、淋巴细胞和细胞凋亡减少的改变
体内的内皮细胞。他们最近发现细胞凋亡途径
LPS 刺激后通过 FADD 依赖性信号传导进行,
NFkappaB 的阻断不会使内皮细胞对死亡敏感。这些
观察引发了有关死亡途径和内在的问题
细胞保护途径。由于 LPS 抗性中发生大量细胞凋亡
(TLR-4 缺陷)小鼠在败血症期间,我们还推测 TLR-2 提供
TLR-4 缺陷小鼠的激活信号和死亡信号。还有,他们
观察到两条导致内皮细胞激活的途径。一、老鼠
缺乏功能性 Fas (lpr) 或 FasL (gld) 会降低对 LPS 的反应,并且
他们推测 Fas-FasL 系统具有促炎作用。二、具体
caspase-8 抑制剂可降低 LPS 诱导的 VCAM-1 表达。他们假设
这种蛋白酶还发出内皮细胞激活信号。具体目标
该项目的主要内容是: 1) 确定 MyD88、Il-1 受体的作用-
脓毒症诱导的相关激酶和 TNF 受体相关因子 6
单核细胞/巨噬细胞和内皮细胞的凋亡; 2)确定
Fas-FasL 和其他分子在细胞凋亡途径中的贡献
LPS诱导的内皮细胞炎症反应; 3) 检查
单核细胞、淋巴细胞或内皮细胞凋亡基因改变的影响
诱导小鼠败血症后的存活率。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT K WINN其他文献
ROBERT K WINN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT K WINN', 18)}}的其他基金
The Role of Bcl-2 in Ischemia-Reperfusion Injury
Bcl-2 在缺血再灌注损伤中的作用
- 批准号:
6740920 - 财政年份:2003
- 资助金额:
$ 23.41万 - 项目类别:
The Role of Bcl-2 in Ischemia-Reperfusion Injury
Bcl-2 在缺血再灌注损伤中的作用
- 批准号:
6888303 - 财政年份:2003
- 资助金额:
$ 23.41万 - 项目类别:
The Role of Bcl-2 in Ischemia-Reperfusion Injury
Bcl-2 在缺血再灌注损伤中的作用
- 批准号:
6611548 - 财政年份:2003
- 资助金额:
$ 23.41万 - 项目类别:
The Role of Bcl-2 in Ischemia-Reperfusion Injury
Bcl-2 在缺血再灌注损伤中的作用
- 批准号:
7056689 - 财政年份:2003
- 资助金额:
$ 23.41万 - 项目类别:
NEUTROPHILS IN ISCHEMIA REPERFUSION INJURY IN SHOCK
休克缺血再灌注损伤中的中性粒细胞
- 批准号:
3301478 - 财政年份:1990
- 资助金额:
$ 23.41万 - 项目类别:
NEUTROPHILS IN ISCHEMIA REPERFUSION INJURY IN SHOCK
休克缺血再灌注损伤中的中性粒细胞
- 批准号:
2181586 - 财政年份:1990
- 资助金额:
$ 23.41万 - 项目类别:
NEUTROPHILS IN ISCHEMIA REPERFUSION INJURY IN SHOCK
休克缺血再灌注损伤中的中性粒细胞
- 批准号:
3301477 - 财政年份:1990
- 资助金额:
$ 23.41万 - 项目类别:
NEUTROPHILS IN ISCHEMIA REPERFUSION INJURY IN SHOCK
休克缺血再灌注损伤中的中性粒细胞
- 批准号:
2181584 - 财政年份:1990
- 资助金额:
$ 23.41万 - 项目类别:
NEUTROPHILS IN ISCHEMIA REPERFUSION INJURY IN SHOCK
休克缺血再灌注损伤中的中性粒细胞
- 批准号:
2444729 - 财政年份:1990
- 资助金额:
$ 23.41万 - 项目类别:
相似国自然基金
脂多糖结合蛋白介导的细菌外膜囊泡招募及铁转运机制研究
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
结核分枝杆菌的拟核结合蛋白Rv0047c参与细菌胁迫应答调控的分子机制研究
- 批准号:31470170
- 批准年份:2014
- 资助金额:80.0 万元
- 项目类别:面上项目
融合肽(钛无机结合肽-富组蛋白5衍生抗菌肽)涂层抑制钛表面细菌生物膜形成的机制和应用研究
- 批准号:31470919
- 批准年份:2014
- 资助金额:75.0 万元
- 项目类别:面上项目
集胞蓝细菌RNA结合蛋白Rbp3的转录后调控功能
- 批准号:31470203
- 批准年份:2014
- 资助金额:84.0 万元
- 项目类别:面上项目
应用SOS恢复系统探寻肺炎链球菌通过血脑屏障的分子机制
- 批准号:30700914
- 批准年份:2007
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Regulation of paraspeckles by STAU1 in neurodegenerative disease
STAU1 在神经退行性疾病中对 paraspeckles 的调节
- 批准号:
10668027 - 财政年份:2023
- 资助金额:
$ 23.41万 - 项目类别:
Stenotrophomonas maltophilia TfcA and TfcB: Antibacterial T4SS effectors from an emerging human pathogen
嗜麦芽寡养单胞菌 TfcA 和 TfcB:来自新兴人类病原体的抗菌 T4SS 效应子
- 批准号:
10661253 - 财政年份:2023
- 资助金额:
$ 23.41万 - 项目类别:
Gut-brain axis at the intersection of aging and traumatic injury
衰老与外伤交叉点的肠脑轴
- 批准号:
10679217 - 财政年份:2023
- 资助金额:
$ 23.41万 - 项目类别:
Mucosal Immune Defense Mechanisms of the Urinary Bladder
膀胱粘膜免疫防御机制
- 批准号:
10587639 - 财政年份:2023
- 资助金额:
$ 23.41万 - 项目类别:
Defining mechanisms of heterogeneity in cell fate decisions during Yersinia pseudotuberculosis infection
假结核耶尔森菌感染期间细胞命运决定异质性的定义机制
- 批准号:
10693867 - 财政年份:2022
- 资助金额:
$ 23.41万 - 项目类别: